Release and aggregation of cytochrome c and α-synuclein are inhibited by the antiparkinsonian drugs, talipexole and pramipexole

J Kakimura, Y Kitamura, K Takata, Y Kohno… - European journal of …, 2001 - Elsevier
Recently, it has been shown that release of cytochrome c from the mitochondria to the
cytosol is required for activation of the caspase-3-dependent cascade in apoptosis, and also …

Central serotonin2C receptor: from physiology to pathology

GD Giovanni, VD Matteo, M Pierucci… - Current topics in …, 2006 - ingentaconnect.com
Since the 1950s, when serotonin (5-HT) was discovered in the mammalian central nervous
system (CNS), an enormous amount of experimental evidence has revealed the pivotal role …

Risperidone in the treatment of dopamine‐induced psychosis in Parkinson's disease: an open pilot trial

E Mohr, T Mendis, K Hildebrand… - … : Official Journal of the …, 2000 - Wiley Online Library
PURPOSE To evaluate the safety and efficacy of risperidone in patients with Parkinson's
disease (PD) who are experiencing significant dopamine‐induced psychosis. PATIENTS …

Antiparkinson prodrugs

A Di Stefano, P Sozio, LS Cerasa - Molecules, 2008 - mdpi.com
Parkinson's disease (PD) is a progressive, neurodegenerative disorder which involves the
loss of dopaminergic neurons of the substantia nigra pars compacta. Current therapy is …

Recent advances in nanotechnology and its application for neuro-disease: a review

K Radhakrishnan, P Senthil Kumar, G Rangasamy… - Applied …, 2023 - Springer
Nanotechnology is an emerging field that is useful for various purposes. Numerous
neurological disorders, such as Parkinson's disease (PD), Alzheimer's disease (AD), stroke …

L-Dopa prodrugs: an overview of trends for improving parkinson's disease treatment

A Di Stefano, P Sozio… - Current …, 2011 - ingentaconnect.com
L-Dopa is the mainstay of Parkinson's disease therapy; this drug is usually administered
orally, but it is extensively metabolized in the gastrointestinal tract, so that relatively little …

Sensitivity to ageing of the limbic dopaminergic system: a review

P Barili, G De Carolis, D Zaccheo, F Amenta - Mechanisms of ageing and …, 1998 - Elsevier
The limbic system includes the complex of brain centres, nuclei and connections that
provide the anatomical substrate for emotions. Although the presence of small amounts of …

Development and validation of a semi-automated method for L-dopa and dopamine in rat plasma using electrospray LC/MS/MS

W Li, DT Rossi, ST Fountain - Journal of pharmaceutical and biomedical …, 2000 - Elsevier
A semi-automated alumina-based extraction method for the determination of l-dopa and
dopamine in plasma using liquid chromatography/mass spectrometry was validated. The …

Striatal Dopamine D2-Muscarinic Acetylcholine M1 Receptor–Receptor Interaction in a Model of Movement Disorders

RAJ Crans, E Wouters, M Valle-León, J Taura… - Frontiers in …, 2020 - frontiersin.org
Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor control
deficits, which is associated with the loss of striatal dopaminergic neurons from the …

Entacapone: a catechol-O-methyltransferase inhibitor for the adjunctive treatment of Parkinson's disease

J Najib - Clinical therapeutics, 2001 - Elsevier
Background: When levodopa therapy is used in Parkinson's disease, degradation of the
drug in the peripheral nervous system is associated with dyskinesias and motor fluctuations …